Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Investigative Dermatology

• Publication date

  1990-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/1523-1747.EP12876121PMID 2161887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-alpha in a breast cancer cell line.

  1989cited by this paper
• Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.

  1989cited by this paper
• Overexpression of transforming growth factor alpha in psoriatic epidermis.

  1989cited by this paper
• The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse. 1962.

  1989cited by this paper
• Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

  1989cited by this paper
• Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.

  1989cited by this paper
• Immunology/inflammation of the skin--a 50-year perspective.

  1989cited by this paper
• Keratinocyte growth regulation by the products of immune cells

  1988cited by this paper
• Immunologic mechanisms in psoriasis.

  1988cited by this paper
• Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques

  1988cited by this paper
• Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes

  1988cited by this paper
• Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)

  1987cited by this paper
• Partial characterization of phospholipase C activity in normal, psoriatic uninvolved, and lesional epidermis.

  1987cited by this paper
• Decreased protein kinase C activity in psoriatic versus normal epidermis.

  1987cited by this paper
• Production and auto-induction of transforming growth factor-α in human keratinocytes

  1987cited by this paper
• Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor.

  1987cited by this paper
• Production and auto-induction of transforming growth factor-alpha in human keratinocytes.

  1987cited by this paper
• Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques

  1986cited by this paper
• Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis.

  1986cited by this paper
• What does epidermal growth factor do and how does it do it?

  1985cited by this paper
• Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin.

  1984cited by this paper
• Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes.

  1984cited by this paper
• Epidermal growth factor.

  1979cited by this paper
• An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis.

  1978cited by this paper
• Epidermal growth factor

  1972cited by this paper
• The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse.

  1963cited by this paper

• Dysregulation of caspase-8 and caspase-9 in T-lymphocyte apoptosis: implications for pathogenesis, diagnosis, and therapeutic targeting in psoriatic arthritis

  2026cites this paper
• Cytokines in psoriasis: From pathogenesis to targeted therapy.

  2024cites this paper
• Modulation of Plet1 expression by N-Acetylglucosamine through the IL-17 A-MAPK pathway in an imiquimod-induced psoriasis mouse model

  2024cites this paper
• Structural and functional imaging of psoriasis for severity assessment and quantitative monitoring of treatment response using high-resolution optoacoustic imaging

  2024cites this paper
• Decreased epidermal AXL expression and increased infiltration of AXL‐expressing dendritic cells in psoriasis

  2023cites this paper
• Recent Update on Immunopathogenesis of Psoriasis

  2022cites this paper
• Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte Proliferation

  2021cites this paper
• Nod-Like Receptors in Host Defence and Disease at the Epidermal Barrier

  2021cites this paper
• IL6R is a target of miR‐197 in human keratinocytes

  2020cites this paper
• CCID_A_281585 889..896

  2020cites this paper
• Galectin-8 is upregulated in keratinocyte by IL-17A and promotes proliferation by regulating mitosis in psoriasis.

  2020cites this paper
• TGF-β1 Gene Polymorphism and Its Correlation with Serum Level of TGF-β1 in Psoriasis Vulgaris Among Iraqi People

  2020cites this paper
• Mechanism and Physiologically Based PK/PD Model in Assisting Translation from Preclinical to Clinical: Understanding PK/PD of Therapeutic Proteins at Site-of-Action

  2019cites this paper
• Protective and pathogenic roles of resident memory T cells in human skin disorders.

  2019cites this paper
• Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR)

  2018cites this paper
• The Tissue-Engineered Human Psoriatic Skin Substitute: A Valuable In Vitro Model to Identify Genes with Altered Expression in Lesional Psoriasis

  2018cites this paper
• Interaction of MTHFR gene with smoking and alcohol use and haplotype combination susceptibility to psoriasis in Chinese population

  2018cites this paper
• MAP Kinases and Prostate Cancer

  2018cites this paper
• Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma

  2017cites this paper
• 13 MAP Kinases and Prostate Cancer

  2017cites this paper
• Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology

  2017cites this paper
• Bazex Syndrome in Lung Squamous Cell Carcinoma: High Expression of Epidermal Growth Factor Receptor in Lesional Keratinocytes with Th2 Immune Shift

  2016cites this paper
• Association between MTHFR 677C/T polymorphism and psoriasis risk: a meta-analysis.

  2015cites this paper
• Pulmonary AlveolarProteinosis in Association withFanconi's Anemia andPsoriasis*

  2015cites this paper
• The translational revolution and use of biologics in patients with inflammatory skin diseases.

  2015cites this paper
• Interleukin 10 Treatment of Psoriasis

  2015cites this paper
• Glycosidated phospholipids - a promising group of anti-tumour lipids.

  2014cites this paper
• The Effects of Indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) on Inflammation Profile in Macrophages

  2014cites this paper
• Effects of magnesium deficiency – More than skin deep

  2014cites this paper
• An Epidemiological Study on Trigger Factors and Quality of Life in Psoriatic Patients

  2014cites this paper
• Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales

  2014cites this paper
• Development Of Dna Aptamers By Cell-Selex Using Yeast Cell Surface Display

  2014cites this paper
• Discovering Aptamers by Cell-SELEX against Human Soluble Growth Factors Ectopically Expressed on Yeast Cell Surface

  2014cites this paper
• Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways

  2013cites this paper
• Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions.

  2013cites this paper
• hMena: altered expression in psoriatic skin

  2013cites this paper
• Drug Class Review: Targeted Immune Modulators

  2012cites this paper
• Cytokine and Anti-Cytokine Therapies for Psoriasis and Atopic Dermatitis

  2012cites this paper
• The treatment of psoriasis with etanercept: An experience from South Kuwait

  2012cites this paper
• Regulation generation: the suppressive functions of human regulatory T cells.

  2012cites this paper
• Association of -619C/T polymorphism in CDSN gene and psoriasis risk: a meta-analysis.

  2011cites this paper
• MAP Kinases and Prostate Cancer

  2011cites this paper
• The role of ZC3H12A in «Pseudomonas aeruginosa» infection of airway epithelial cells and implication in Cystic Fibrosis

  2011cites this paper
• MCP-l D 1 RNA Expression in Basal Keratinocytes of Psoriatic Lesions

  2010cites this paper
• IL-6 Signals Through pStat3 to Prevent Functional Immune Suppression by Human Regulatory T Cells

  2010cites this paper
• NK cells in the eye

  2010cites this paper
• Identification of glucocorticoid-induced TNF receptor-related protein ligand on keratinocytes: ligation by GITR induces keratinocyte chemokine production and augments T-cell proliferation.

  2009influential citation
• Serum and tissue expression of transforming growth factor beta 1 in psoriasis

  2009cites this paper
• Apurinic/Apyrimidinic Endonuclease 1 Is a Key Modulator of Keratinocyte Inflammatory Responses1

  2009cites this paper
• Antígeno prostático-específico, citoquinas pro-inflamatorias y patología prostática (Hiperplasia benigna y Cáncer): Relación con la malignidad

  2009cites this paper
• This information is current as Inflammatory Responses Key Modulator of Keratinocyte Apurinic / Apyrimidinic Endonuclease 1 Is a

  2009cites this paper
• Apoptotic View to What Happens at Periphery in Psoriasis

  2009cites this paper
• Significance of heat shock proteins in the skin upon UV exposure.

  2009cites this paper
• Regulation of Cell Proliferation and Migration by TAK1 via Transcriptional Control of von Hippel-Lindau Tumor Suppressor*

  2009cites this paper
• [Prostatic specific antigen (PS), pro-inflammatory cytokines, and prostatic pathology (benign prostatic hyperplasia and cancer). Relationship with malignancy].

  2009cites this paper
• Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer.

  2008cites this paper
• Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells.

  2008cites this paper
• Update on the natural history and systemic treatment of psoriasis.

  2008cites this paper
• Interleukin-6 and Interleukin-6 Soluble Receptor Regulate Proliferation of Normal, Human Papillomavirus-Immortalized, and Carcinoma-Derived Cervical Cells in Vitro cervical

  2007cites this paper
• Srcasm overexpression in psoriasis‐insights into pathogenesis

  2007cites this paper
• Oral keratinocytes derived from the peritonsillar mucosa express the proinflammatory cytokine IL-6 without prior stimulation.

  2007cites this paper
• Analysis of perforin expression in peripheral blood and lesions in severe and mild psoriasis.

  2007cites this paper
• Srcasm Corrects Fyn-induced Epidermal Hyperplasia by Kinase Down-regulation*

  2007cites this paper
• Prolonged MHC class II expression and CIITA transcription in human keratinocytes.

  2006cites this paper
• Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.

  2006cites this paper
• Psoriasis : diagnostic et étiopathogénie

  2006cites this paper
• Role of fibroblasts as the principal factor in differentiation of the epidermis

  2006cites this paper
• Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.

  2006cites this paper
• In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models

  2005cites this paper
• Effect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scales.

  2005cites this paper
• What must a model display for proof as a model of psoriasis?

  2005cites this paper
• IL‐6, its receptors and its relationship with bcl‐2 and bax proteins in infiltrating and in situ human breast carcinoma

  2005cites this paper
• Cyclosporin A, FK506 and dithranol alter tyrosine-specific protein phosphorylation in HaCaT keratinocytes

  2005cites this paper
• The treatment of psoriasis with etanercept.

  2005cites this paper
• Novel pharmacological approaches in the treatment of psoriasis

  2005cites this paper
• Effect of psoriasis treatment on plasma concentrations of metalloproteinase‐1 and tissue inhibitor of metalloproteinases‐1

  2005cites this paper
• Impairments in complement receptor- and Fc receptor-mediated functions in vivo in patients with psoriasis

  2005cites this paper
• Possible role of Malassezia furfur in psoriasis: modulation of TGF‐β1, integrin, and HSP70 expression in human keratinocytes and in the skin of psoriasis‐affected patients

  2004cites this paper
• Phenotypic determination of T-lymphocytes responding to chemotactic stimulation from fMLP, IL-8, human IL-10, and epidermal lymphocyte chemotactic factor

  2004cites this paper
• Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris

  2004cites this paper
• Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis

  2004cites this paper
• Pulmonary alveolar proteinosis associated with psoriasis and complicated by mycobacterial infection: Successful treatment with granulocyte‐macrophage colony stimulating factor after a partial response to whole lung lavage

  2004cites this paper
• Etanercept in psoriasis

  2004cites this paper
• Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.

  2004cites this paper
• Current concepts in the immunopathogenesis of psoriasis.

  2004cites this paper
• Role of Keratinocytes in Antigen Presentation and Polarization of Human T Lymphocytes

  2004cites this paper
• Normalized proliferation of normal and psoriatic keratinocytes by suppression of sAPPalpha-release.

  2004cites this paper
• Antisense oligonucleotide treatments for psoriasis

  2004cites this paper
• Immunohistochemical studies on NAP-1/IL-8 in contact eczema and atopic dermatitis

  2004cites this paper
• T-Cell Idltrates in Different Stages of the Disease Uninvolved Psoriatic Skin

  2004cites this paper
• Quantification and localization of platelet-derived growth factor in gingiva of periodontitis patients.

  2003cites this paper
• Plasma transforming growth factor β1 as a biomarker of psoriasis activity and treatment efficacy

  2003cites this paper
• Immunology of Uveal Melanoma: Immunosuppressive Factors and the Basis for Immunotherapy

  2003cites this paper
• Clinical and Laboratory Investigations Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis

  2003cites this paper
• Connections between psoriasis and Crohn's disease.

  2003cites this paper
• HCR, a candidate gene for psoriasis, is expressed differently in psoriasis and other hyperproliferative skin disorders and is downregulated by interferon-gamma in keratinocytes.

  2003cites this paper
• Downregulation of epidermal growth factor receptor signaling by singlet oxygen through activation of caspase-3 and protein phosphatases

  2003cites this paper
• Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblings.

  2003cites this paper
• Reciprocal altered expression of T‐cadherin and P‐cadherin in psoriasis vulgaris

  2003cites this paper
• Potential of p38 MAP kinase inhibitors in the treatment of cancer.

  2003cites this paper